Metachromatic leukodystrophy is an autosomal recessive neurodegenerative lysosomal disease characterized by a deficiency of the lysosomal enzyme arylsulfatase A and the subsequent accumulation of sulfatide in neuronal and visceral tissues. Clinical diagnosis is usually confirmed by in vitro analysis of arylsulfatase A activity but may be complicated in cases of arylsulfatase A pseudodeficiency and sphingolipid activators protein deficiency. We report the case of a 3-year-old boy who presented a severe form of late infantile metachromatic leukodystrophy. This patient was found to be homozygous for the arylsulfatase A pseudodeficiency. This condition is rare and can lead to a severe disease. Prenatal diagnosis was performed in this family, and the fetus was healthy.
Von Figura K., Gieselmann V., Jaeken J.Metachromatic leukodystrophy. In: Scriver CR, Beaudet AL, Valle D, et al., eds. The Metabolic and Molecular Bases of Inherited Diseases. 8th ed. New York: McGraw-Hill; 2001:3695-3724.
2.
Baum H., Dodgson KS, Spencer B.The assay of arylsulphatase A and B in human urine. Clin Chim Acta. 1959;4(3):453-455.
3.
Gieselmann V. , Polten A., Kreysing J., Von Figura K.Arylsulfatase A pseudodeficiency: loss of a polyadenylylation signal and N-glycosylation site. Proc Natl Acad Sci USA. 1989; 86(23):9436-9440.
4.
Gieselmann V. , Fluharty AL, Tonnesen T., Von Figura K.Mutations in the arylsulfatase A pseudodeficiency allele causing metachromatic leukodystrophy. Am J Hum Genet . 1991; 49(1-2):407-413.
5.
Regis S., Filocamo M., Stroppiano M., et al. A 9-bp deletion (2320de19) on the background of the arylsulfatase A pseudodeficiency allele in a metachromatic leukodystrophy patient and in a patient with nonprogressive neurological symptoms. Hum Genet . 1998;102(1):50-53.
6.
Ricketts MH, Zhang X., Manowitz PAMethod for rapid detection of arylsulfatase A pseudodeficiency mutations. Hum Hered. 1995;45(4):235-240.
7.
Wang PJ, Hwu WL, Shen YZEpileptic seizures and electroencephalographic evolution in genetic leukodystrophies . J Clin Neurophysiol. 2001;18(1):25-32.
8.
Cameron CL, Kang PB, Burns TM, Darras BT, Jones HR Jr.Multifocal slowing of nerve conduction in metachromatic leukodystrophy. Muscle Nerve. 2004;29(4):531-536.
9.
Polten A., Fluharty AL, Fluharty CB, Kappler J., Von Figura K., Gieselmann V.Molecular basis of different forms of metachromatic leukodystrophy. N Engl J Med. 1991;324(1):18-22.
10.
Leinekugel P., Michel S., Conzelmann E., Sandhoff K.Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum Genet. 1992;88(5):513-523.
11.
Porter MT, Fluharty AL, Trammell J., Kihara H.A correlation of intracellular cerebroside sulfatase activity in fibroblasts with latency in metachromatic leukodystrophy. Biochem Biophys Res Commun. 1991;44(3):660-666.
12.
Kihara H., Ho CK, Fluharty AL, Tsay KK, Hartlage PLPrenatal diagnosis of metachromatic leukodystrophy in a family with pseudoarylsulfatase A deficiency by the cerebroside sulfate loading test. Pediatr Res. 1980;14(3):224-227.
13.
Desnick RJ, Dawson G., Desnick SJ, Sweeley CC, Krivit W.Diagnosis of glycosphingolipidoses by urinary-sediment analysis. N Engl J Med. 1971;284(14):739-744.
14.
Strasberg PM, Warren I., Skomorowski MA, Lowden JAHPLC analysis of urinary sulfatide: an aid in the diagnosis of metachromatic leukodystrophy. Clin Biochem. 1985;18(2):92-97.
15.
Fredman P., Mattsson L., Andersson K., et al. Characterization of the binding epitope of a monoclonal antibody to sulphatide. Biochem J. 1988;251(1):17-22.
16.
Penzien JM, Kappler J., Herschkowitz N., et al. Compound heterozygosity for metachromatic leukodystrophy and arylsulfatase A pseudodeficiency alleles is not associated with progressive neurological disease. Am J Hum Genet. 1993 ;52(3):557-564.
17.
Biffi A., Cesani M., Fumagalli F., et al. Metachromatic leukodystrophy-mutation analysis provides further evidence of genotype-phenotype correlation. Clin Genet. 2008;74(4): 349-357.
18.
Polten A., Fluharty AL, Fluharty CB, Kappler J., Von Figura K., Gieselmann V.Molecular basis of different forms of metachromatic leukodystrophy. N Engl J Med. 1991;324(1):424-425.
19.
Gieselmann V., Polten A., Kreysing J., et al. Molecular genetics of metachromatic leukodystrophy. Dev Neurosci. 1991; 13(4-5):222-227.
20.
Berger J., Loschl B., Bernheimer H., et al. Occurrence, distribution, and phenotype of arylsulfatase A mutations in patients with metachromatic leukodystrophy. Am J Med Genet . 1997; 69(3):335-340.
21.
Regis S., Filocamo M., Stroppiano M., Corsolini F., Gatti R.Molecular analysis of the arylsulphatase A gene in late infantile metachromatic leucodystrophy patients and healthy subjects from Italy. J Med Genet. 1996;33(3):251-252.
22.
Krivit W., Aubourg P., Shapiro E., Peters C.Bone marrow transplantation for globoid cell leukodystrophy, adrenoleukodystrophy, metachromatic leukodystrophy, and Hurler syndrome. Curr Opin Hematol. 1999;6(6):377-382.
23.
Martino S., Consiglio A., Cavalieri C., et al. Expression and purification of a human, soluble Arylsulfatase A for Metachromatic Leukodystrophy enzyme replacement therapy. J Biotechnol. 2005;117(3):243-251.
24.
Matzner U., Matthes F., Weigelt C., et al. Non-inhibitory antibodies impede lysosomal storage reduction during enzyme replacement therapy of a lysosomal storage disease. J Mol Med. 2008;86(4):433-442.
